Literature DB >> 10810408

Missense alterations of BRCA1 gene detected in diverse cancer patients.

D Shen1, Y Wu, R Chillar, J V Vadgama.   

Abstract

The mutations in the breast cancer susceptible gene BRCA1 are responsible for about 50% of inherited breast cancers and confer increased risk of breast and ovarian cancer to its carriers. BRCA1 gene mutations may also be related with other types of cancers such as prostate cancer and colorectal cancer. The goal of this study was to investigate if BRCA1 mutation could be detected in diverse types of cancers. We used PCR-NIRCA and PCR-SSCP methods for screening the BRCA1 mutation hot regions, exons 2, 5, 11, 16 and 20. The positive samples were sequenced to confirm the nature of the mutations. We have identified a rare sequence variant, A3537G (Ser 1140Gly) in a B cell lymphoma patient and two polymorphisms, A1186G (Gln356Arg) in a brain cancer patient and A3667G (Lys1183Arg) in a germline tumor patient. In conclusion, 3 missense alterations of BRCA1 gene have been identified in cancers other than breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810408

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase.

Authors:  Qiong Wei; Liqun Wang; Qiang Wang; Warren D Kruger; Roland L Dunbrack
Journal:  Proteins       Date:  2010-07

2.  Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers.

Authors:  Masatoshi Haseba; Shigekazu Hidaka; Takashi Tsuji; Hiroshi Yano; Hideaki Komatsu; Terumitu Sawai; Toru Yasutake; Tohru Nakagoe; Yutaka Tagawa; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.